Levonest NDC 16714-340

NDC codes

FDA NDC Directory

Product NDC (as listed)16714-340Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16714-0340Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
16714-340-01	16714034001	1 BLISTER PACK in 1 PACKET (16714-340-01) / 1 KIT in 1 BLISTER PACKMarketed from Dec 29, 2010
16714-340-02	16714034002	1 BLISTER PACK in 1 CARTON (16714-340-02) / 1 KIT in 1 BLISTER PACKMarketed from Dec 29, 2010
16714-340-03	16714034003	3 BLISTER PACK in 1 CARTON (16714-340-03) / 1 KIT in 1 BLISTER PACKMarketed from Dec 29, 2010
16714-340-04	16714034004	6 BLISTER PACK in 1 CARTON (16714-340-04) / 1 KIT in 1 BLISTER PACKMarketed from Dec 29, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levonest
Generic name (nonproprietary): levonorgestrel and ethinyl estradiol
Dosage form: Kit
Labeler: Northstar Rx LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090719
Marketing start: Dec 29, 2010
Listing expires: Dec 31, 2026
Identifiers: Product ID 16714-340_8057bfb7-5eeb-404f-9614-4e629c2d1f4bSPL ID 8057bfb7-5eeb-404f-9614-4e629c2d1f4bSPL set ID be7000f1-5bf1-4de5-a256-e4436c37f0a1RxCUI 310230, 348804, 348805, 748797, 748832, 1095227

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N416714034001 followed by a unit qualifier and the quantity

Package 16714-0340-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2025.

Indications (excerpt from the label)

Indications and Usage Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization and the IUD, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. TABLE I: PERCENTAGE OF WOMEN EXPERIENCING AN UNINTENDED PREGNANCY DURING THE FIRST YEAR OF USE OF A CONTRACEPTIVE METHOD Method Perfect Use Typical Use Levonorg…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090719

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090719
Product	Strength	Form · route	Labeler	Product NDC
Levonestlevonorgestrel and ethinyl estradiol	—	Kit	A-S Medication Solutions	50090-2505